| Dr Mourhege M Al-saloum, MD | |
|
1874 Pelham Pkwy S, Bronx, NY 10461-3733 | |
| (718) 931-5800 | |
| Not Available |
| Full Name | Dr Mourhege M Al-saloum |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 41 Years |
| Location | 1874 Pelham Pkwy S, Bronx, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417922337 | NPI | - | NPPES |
| 01665690 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 196033 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trude Weishaupt Memorial Dialysis Center | Fresh meadows, NY | Dialysis facility |
| New York-presbyterian/queens | Flushing, NY | Hospital |
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York Queens Medicine And Surgery, P.c. | 4082883673 | 371 |
| Nephrology Associates,p.c. | 8921999368 | 7 |
News Archive
Teacher training followed by classroom education with information, activities, and emotional support improves lifestyles in teachers and students, according to research to be presented at ESC Congress 2019 together with the World Congress of Cardiology.
Russia's HIV/AIDS epidemic "has defied worldwide trends, expanding more rapidly year by year than almost anywhere else," the New York Times writes in an article that examines how the country has become "one of the world's low points in the effort to fight the spread of HIV," in large part due to the government's failure to reach out to injecting drug users (IDUs) and sex workers - the groups "at the heart" of the epidemic.
Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield's biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
› Verified 4 days ago
| Entity Name | Nephrology Associates,p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740382886 PECOS PAC ID: 8921999368 Enrollment ID: O20040323002071 |
News Archive
Teacher training followed by classroom education with information, activities, and emotional support improves lifestyles in teachers and students, according to research to be presented at ESC Congress 2019 together with the World Congress of Cardiology.
Russia's HIV/AIDS epidemic "has defied worldwide trends, expanding more rapidly year by year than almost anywhere else," the New York Times writes in an article that examines how the country has become "one of the world's low points in the effort to fight the spread of HIV," in large part due to the government's failure to reach out to injecting drug users (IDUs) and sex workers - the groups "at the heart" of the epidemic.
Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield's biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
› Verified 4 days ago
| Entity Name | Newyork-presbyterian-queens |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013960962 PECOS PAC ID: 7315839933 Enrollment ID: O20040329000273 |
News Archive
Teacher training followed by classroom education with information, activities, and emotional support improves lifestyles in teachers and students, according to research to be presented at ESC Congress 2019 together with the World Congress of Cardiology.
Russia's HIV/AIDS epidemic "has defied worldwide trends, expanding more rapidly year by year than almost anywhere else," the New York Times writes in an article that examines how the country has become "one of the world's low points in the effort to fight the spread of HIV," in large part due to the government's failure to reach out to injecting drug users (IDUs) and sex workers - the groups "at the heart" of the epidemic.
Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield's biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
› Verified 4 days ago
| Entity Name | New York Queens Medicine And Surgery, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003114851 PECOS PAC ID: 4082883673 Enrollment ID: O20110817000163 |
News Archive
Teacher training followed by classroom education with information, activities, and emotional support improves lifestyles in teachers and students, according to research to be presented at ESC Congress 2019 together with the World Congress of Cardiology.
Russia's HIV/AIDS epidemic "has defied worldwide trends, expanding more rapidly year by year than almost anywhere else," the New York Times writes in an article that examines how the country has become "one of the world's low points in the effort to fight the spread of HIV," in large part due to the government's failure to reach out to injecting drug users (IDUs) and sex workers - the groups "at the heart" of the epidemic.
Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield's biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mourhege M Al-saloum, MD 1874 Pelham Pkwy S, Bronx, NY 10461-3733 Ph: (718) 931-5800 | Dr Mourhege M Al-saloum, MD 1874 Pelham Pkwy S, Bronx, NY 10461-3733 Ph: (718) 931-5800 |
News Archive
Teacher training followed by classroom education with information, activities, and emotional support improves lifestyles in teachers and students, according to research to be presented at ESC Congress 2019 together with the World Congress of Cardiology.
Russia's HIV/AIDS epidemic "has defied worldwide trends, expanding more rapidly year by year than almost anywhere else," the New York Times writes in an article that examines how the country has become "one of the world's low points in the effort to fight the spread of HIV," in large part due to the government's failure to reach out to injecting drug users (IDUs) and sex workers - the groups "at the heart" of the epidemic.
Makefield Therapeutics, Inc., an emerging therapeutics company, today announced that it has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield's biodegradable Hybrid Nanoparticles™, a versatile new drug delivery platform.
Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data from a phase II study evaluating AGS-1C4D4 in metastatic pancreatic cancer in a poster session at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago.
› Verified 4 days ago
Selina Sultana Zaman, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Nephrology Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |